First mRNA flu vaccine brings COVID-era concerns into flu vaccine conversations

Public discussion of mFlusiva has included substantial doubt and distrust, much of it carried over from COVID-19 vaccine conversations. Alongside that skepticism, people are asking practical questions about vaccine choice, eligibility, side effects, and access.